| Immunogenicity and structures of a rationally designed prefusion MERS-CoV spike antigen J Pallesen, N Wang, KS Corbett, D Wrapp, RN Kirchdoerfer, HL Turner, ... Proceedings of the National Academy of Sciences 114 (35), E7348-E7357, 2017 | 1052 | 2017 |
| Pre-fusion structure of a human coronavirus spike protein RN Kirchdoerfer, CA Cottrell, N Wang, J Pallesen, HM Yassine, HL Turner, ... Nature 531 (7592), 118-121, 2016 | 808 | 2016 |
| Stabilized coronavirus spikes are resistant to conformational changes induced by receptor recognition or proteolysis RN Kirchdoerfer, N Wang, J Pallesen, D Wrapp, HL Turner, CA Cottrell, ... Scientific reports 8 (1), 15701, 2018 | 509 | 2018 |
| Structural analysis of full-length SARS-CoV-2 spike protein from an advanced vaccine candidate S Bangaru, G Ozorowski, HL Turner, A Antanasijevic, D Huang, X Wang, ... Science 370 (6520), 1089-1094, 2020 | 317 | 2020 |
| Isolation of potent neutralizing antibodies from a survivor of the 2014 Ebola virus outbreak ZA Bornholdt, HL Turner, CD Murin, W Li, D Sok, CA Souders, AE Piper, ... Science 351 (6277), 1078-1083, 2016 | 227 | 2016 |
| Universal protection against influenza infection by a multidomain antibody to influenza hemagglutinin NS Laursen, RHE Friesen, X Zhu, M Jongeneelen, S Blokland, J Vermond, ... Science 362 (6414), 598-602, 2018 | 202 | 2018 |
| A site of vulnerability on the influenza virus hemagglutinin head domain trimer interface S Bangaru, S Lang, M Schotsaert, HA Vanderven, X Zhu, N Kose, ... Cell 177 (5), 1136-1152. e18, 2019 | 201 | 2019 |
| Author Correction: A Engineered immunogen binding to alum adjuvant enhances humoral immunity TJ Moyer, Y Kato, W Abraham, JYH Chang, DW Kulp, N Watson, ... Nature Medicine 26 (5), 804-804, 2020 | 195* | 2020 |
| Systematic analysis of monoclonal antibodies against Ebola virus GP defines features that contribute to protection EO Saphire, SL Schendel, ML Fusco, K Gangavarapu, BM Gunn, AZ Wec, ... Cell 174 (4), 938-952. e13, 2018 | 187 | 2018 |
| Electron-microscopy-based epitope mapping defines specificities of polyclonal antibodies elicited during HIV-1 BG505 envelope trimer immunization M Bianchi, HL Turner, B Nogal, CA Cottrell, D Oyen, M Pauthner, ... Immunity 49 (2), 288-300. e8, 2018 | 173 | 2018 |
| Cross-reactive and potent neutralizing antibody responses in human survivors of natural ebolavirus infection AI Flyak, X Shen, CD Murin, HL Turner, JA David, ML Fusco, R Lampley, ... Cell 164 (3), 392-405, 2016 | 172 | 2016 |
| Two-component spike nanoparticle vaccine protects macaques from SARS-CoV-2 infection PJM Brouwer, M Brinkkemper, P Maisonnasse, N Dereuddre-Bosquet, ... Cell 184 (5), 1188-1200. e19, 2021 | 155 | 2021 |
| Development of clinical-stage human monoclonal antibodies that treat advanced Ebola virus disease in nonhuman primates KE Pascal, D Dudgeon, JC Trefry, M Anantpadma, Y Sakurai, CD Murin, ... The Journal of infectious diseases 218 (suppl_5), S612-S626, 2018 | 154 | 2018 |
| Antibodies from a human survivor define sites of vulnerability for broad protection against ebolaviruses AZ Wec, AS Herbert, CD Murin, EK Nyakatura, DM Abelson, JM Fels, ... Cell 169 (5), 878-890. e15, 2017 | 149 | 2017 |
| Vaccination with glycan-modified HIV NFL envelope trimer-liposomes elicits broadly neutralizing antibodies to multiple sites of vulnerability V Dubrovskaya, K Tran, G Ozorowski, J Guenaga, R Wilson, S Bale, ... Immunity 51 (5), 915-929. e7, 2019 | 121 | 2019 |
| Immunization-elicited broadly protective antibody reveals ebolavirus fusion loop as a site of vulnerability X Zhao, KA Howell, S He, JM Brannan, AZ Wec, E Davidson, HL Turner, ... Cell 169 (5), 891-904. e15, 2017 | 107 | 2017 |
| Structures of Ebola virus GP and sGP in complex with therapeutic antibodies J Pallesen, CD Murin, N De Val, CA Cottrell, KM Hastie, HL Turner, ... Nature microbiology 1 (9), 1-9, 2016 | 107 | 2016 |
| Antibody-dependent enhancement of influenza disease promoted by increase in hemagglutinin stem flexibility and virus fusion kinetics KL Winarski, J Tang, L Klenow, J Lee, EM Coyle, J Manischewitz, ... Proceedings of the National Academy of Sciences 116 (30), 15194-15199, 2019 | 89 | 2019 |
| Antibody treatment of Ebola and Sudan virus infection via a uniquely exposed epitope within the glycoprotein receptor-binding site KA Howell, X Qiu, JM Brannan, C Bryan, E Davidson, FW Holtsberg, ... Cell reports 15 (7), 1514-1526, 2016 | 88 | 2016 |
| Glycosylation of human IgA directly inhibits influenza A and other sialic-acid-binding viruses MA Maurer, L Meyer, M Bianchi, HL Turner, NPL Le, M Steck, A Wyrzucki, ... Cell reports 23 (1), 90-99, 2018 | 87 | 2018 |
Christopher A CottrellThe Scripps Research InstituteVerified email at scripps.edu
